Antibody production
-
Antibody production
How will monoclonal antibody production by hybridoma technology evolve in the coming decades
For the past decades, the hybridoma technology has allowed us to leverage potent and highly specific antibodies for therapy, research, and diagnostics. However, with the increasing demand for new antibody…
-
Will camelid antibodies offer a solution to solve the COVID-19 pandemic?
The emergence of the zoonotic pathogen, SARS-CoV-2, resulted in a global pandemic and caused the deaths of hundreds of thousands… Read More
-
Can mRNA therapeutics overcome the limitations of typical monoclonal antibody production processes?
Antibodies have driven the development of research and medicine. Their specificity, stability, and reduced immunogenicity have made them one of… Read More
-
What are chimeric antibodies?
Considered by many researchers as intermediate molecules, chimeric antibody constructs have been gradually losing ground to more effective molecules such… Read More
-
How are mouse monoclonal antibodies humanized: current approaches and limitations
Mouse monoclonal antibodies were the first to ever be produced in vitro. However, early-stage clinical evaluation of these molecules led… Read More
-
Fully human antibodies that will make the news in 2020
As the demand for fully human antibodies continues to rise, so does the proportion of clinical approvals of this type… Read More
-
Why humanized antibody production may thrive in the 2020s
For the first time, humanized and fully human antibodies are almost on equal terms. Up to 2019, 38 humanized antibodies… Read More
-
Antibody production: rabbit versus mouse, which host best fits your project?
In recent years, rabbit monoclonal antibody production using phage display has been sought after by researchers and industry leaders… Read More
-
Antibody therapeutics in clinical trials for the treatment of COVID-19
The race for the repurposing and development of treatments for COVID-19 continues amidst conflicting data on the new strain of… Read More
-
COVID-19 antibodies, antigens, and services
SARS-CoV-2 is a new Betacoronavirus responsible for the COVID-19 respiratory outbreak. The virus is also the third of the genus… Read More